Theresa Y. MacDonald

Cornell University — United States

Medicine · Health Sciences

26h-index9.7kcitations91works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(59), Cancer, Lipids, and Metabolism(17), Prostate Cancer Diagnosis and Treatment(14), Cancer Genomics and Diagnostics(12), Radiopharmaceutical Chemistry and Applications(11)

Publications91 total

Genome Sequencing Identifies Monogenic Causes in Adults with Metabolic Diseases

2025Open Access

Feasibility of implementing whole genome sequencing into routine oncology care.

Journal of Clinical Oncology·2024

P589: Diagnostic yield of digital gene panel from genome sequencing in common multifactorial endocrine and metabolic disorders

Genetics in Medicine Open·2024Open Access

Data from Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

2023Open Access

Supplementary Figures 1-15, Supplementary Tables 1-2, Supplementary Methods from Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

2023Open Access

Supplementary Table 3 from Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

2023Open Access

Data from Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

2023Open Access

Supplementary Figures 1-15, Supplementary Tables 1-2, Supplementary Methods from Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

2023Open Access

Supplementary Table 3 from Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

2023Open Access

Data from Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men

2023Open Access

Data from Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men

2023Open Access

Data Supplement from Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men

2023Open Access

Supplementary Table 1 from SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity

2023Open Access

Data from SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity

2023Open Access

Data Supplement from Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men

2023Open Access

Supplementary Figure 3 from SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity

2023Open Access

Data Supplement from Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men

2023Open Access

Supplementary Table 1 from SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity

2023Open Access

Supplementary Figure 2 from SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity

2023Open Access

Supplementary Figure 1 from SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity

2023Open Access

page 1 of 5Next →

Frequent Co-authors

Mark A. Rubin(48), Juan Miguel Mosquera(31), Kyung Park(24), Andrea Sboner(22), Himisha Beltran(22), Francesca Demichelis(18), Ashutosh Tewari(14), Christopher E. Barbieri(14), Olivier Elemento(14), David S. Rickman(14), Scott T. Tagawa(12), David M. Nanus(12), Brian D. Robinson(12), Naoki Kitabayashi(7), Mark Gerstein(7), Zhengming Chen(7), Mirjam Blattner(7), Gunther Boysen(6), Stéphane Terry(6), Arul M. Chinnaiyan(6)